ANI Pledges To Keep Snapping Up Assets And Partnering

US niche generics and brands player ANI Pharmaceuticals intends to keep using its cash flow to fund product acquisitions and partnerships, particularly in the injectables arena.

Basket
ANI Pharmaceuticals intends to keep shopping for baskets of ANDAs in the US • Source: Shutterstock

US-based specialty pharma player ANI Pharmaceuticals plans to continue with its strategy of building out both its pipeline and its marketing portfolio through acquisitions and alliances, rather than developing drugs on its own.

“We have substantial firepower to pursue strategic opportunities and we intend to continue to use our cash and cash availability...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Generics Bulletin for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Deals

More from Business